LEGEND BIOTECH CORPORATION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 45.26 USD | -0.33% |
|
+0.27% | -24.78% |
| 04-23 | Genscript Biotech Unit Gets Approval for Blood Cancer Drug by European Commission | MT |
| 04-22 | Legend Biotech's Carvykti Gets European Commission Approval for Treatment of Blood Cancer | MT |
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| LEGEND BIOTECH CORPORATION | Bio Therapeutic Drugs | -0.33% | +0.27% | -24.78% | -32.44% | - | 8.23B |  | | |
- Stock Market
- Equities
- LEGN Stock
- Charts Legend Biotech Corporation
- Relative Strength Chart
